test Browse by Author Names Browse by Titles of Works Browse by Subjects of Works Browse by Issue Dates of Works

Advanced Search
& Collections
Issue Date   
Sign on to:   
Receive email
My Account
authorized users
Edit Profile   
About T-Space   

T-Space at The University of Toronto Libraries >
School of Graduate Studies - Theses >
Master >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1807/30581

Title: Evaluation of Pharmacotherapy for Common Medical Conditions in Pregnancy
Authors: Ebrahimi, Neda
Advisor: Koren, Gideon
Department: Pharmaceutical Sciences
Keywords: Pharmaceutical Sciences
Clinical Pharmacology
Issue Date: 7-Dec-2011
Abstract: Purpose Two new scales, CORECTS and PUQE-24 are introduced and validated, and the safety and effectiveness of Proctofoam-HC® in pregnancy is demonstrated. Method 315 of Motherisk NVP patients provided information on five clinical parameters as well as PUQE scores. 28 patients visiting a proctologist were graded for the severity of anal conditions by a proctologist before administering CORECTS. Pre and postnatal interviews were conducted with 204 pregnant women prescribed Proctofoam-HC®. Results Strong correlations were found between the following: PUQE-24 scores and parameters of well-being, hospitalization, and multivitamin intake; bleeding and pain components of CORECTS and the proctologist’s grade.There was no significant difference between mean birth weight of Proctofoam-HC® treated and comparison groups. There was a significant reduction in all symptoms of hemorrhoids. Conclusion PUQE-24 and CORECTS are the first validated scales used to assess the severity of NVP and hemorrhoids. Proctofoam-HC® is safe and effective for use in pregnancy.
URI: http://hdl.handle.net/1807/30581
Appears in Collections:Master

Files in This Item:

File Description SizeFormat
Ebrahimi_Neda_201111_MSc_thesis.pdf1.35 MBAdobe PDF

Items in T-Space are protected by copyright, with all rights reserved, unless otherwise indicated.